Ani Pharmaceuticals Inc (ANIP)
EBITDA Growth
53.84%
Quarterly · Period ending:
ANIP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported53.84%period ending
Latest reported53.84%period ending
ANIP Quarterly EBITDA YoY % (-365.21% → 53.84%)
Year-over-year change
High-resolution chart · PNG
ANIP ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 41.4558% | |
| -39.9507% | |
| -365.2118% |